IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production.
暂无分享,去创建一个
K. Coggeshall | D. Drevets | H. Mehta | K. Maeda | Kenichiro Maeda | Douglas A. Drevets | Harshini Mehta | K. Coggeshall
[1] P. Sfikakis,et al. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. , 2010, Seminars in arthritis and rheumatism.
[2] R. Flavell,et al. SHIP Represses the Generation of IL-3-Induced M2 Macrophages by Inhibiting IL-4 Production from Basophils1 , 2009, The Journal of Immunology.
[3] K. Coggeshall,et al. Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. , 2009, Blood.
[4] M. Glogauer,et al. Adaptor Protein SLAT Modulates Fcγ Receptor-mediated Phagocytosis in Murine Macrophages* , 2009, Journal of Biological Chemistry.
[5] H. Anders,et al. The role of innate immunity in autoimmune tissue injury , 2008, Current opinion in rheumatology.
[6] Mikkel Ostergaard,et al. Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome. , 2008, The Journal of rheumatology.
[7] G. Schett. Review: Immune cells and mediators of inflammatory arthritis , 2008, Autoimmunity.
[8] R. Cornall,et al. MyD88‐dependent autoimmune disease in Lyn‐deficient mice , 2007, European journal of immunology.
[9] C. Suh,et al. Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus , 2007, Journal of Clinical Immunology.
[10] D. Fruman,et al. Role of phosphoinositide 3-kinase signaling in autoimmunity , 2007, Autoimmunity.
[11] Xiao-yu R. Song,et al. Anti‐interleukin‐6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus , 2006, Immunology.
[12] T. Mayadas,et al. Vav Proteins in Neutrophils Are Required for FcγR-Mediated Signaling to Rac GTPases and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Component p40(phox)1 , 2006, The Journal of Immunology.
[13] M. Caligiuri,et al. FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways. , 2006, Blood.
[14] G. Firestein. Inhibiting inflammation in rheumatoid arthritis. , 2006, The New England journal of medicine.
[15] A. Mui,et al. SHIP represses the generation of alternatively activated macrophages. , 2005, Immunity.
[16] Emilio Hirsch,et al. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis , 2005, Nature Medicine.
[17] D. F. Barber,et al. PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus , 2005, Nature Medicine.
[18] Y. Baba,et al. IL-6 blocks a discrete early step in lymphopoiesis. , 2005, Blood.
[19] V. Vedham,et al. Vav Activation and Function as a Rac Guanine Nucleotide Exchange Factor in Macrophage Colony-Stimulating Factor-Induced Macrophage Chemotaxis , 2005, Molecular and Cellular Biology.
[20] Michael C. Ostrowski,et al. The Serine/Threonine Kinase Akt Promotes Fcγ Receptor-mediated Phagocytosis in Murine Macrophages through the Activation of p70S6 Kinase* , 2004, Journal of Biological Chemistry.
[21] C. Quilici,et al. Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. , 2004, Blood.
[22] A. Roberts,et al. Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] G. Krystal,et al. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. , 2004, Immunity.
[24] D. Fruman. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. , 2004, Current opinion in immunology.
[25] P. Lipsky,et al. Rationale for interleukin-6 blockade in systemic lupus erythematosus , 2004, Lupus.
[26] N. Van Rooijen,et al. Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1 , 2004, The Journal of Immunology.
[27] K. Coggeshall,et al. Src Homology 2–containing 5-Inositol Phosphatase (SHIP) Suppresses an Early Stage of Lymphoid Cell Development through Elevated Interleukin-6 Production by Myeloid Cells in Bone Marrow , 2004, The Journal of experimental medicine.
[28] S. Koyasu. The role of PI3K in immune cells , 2003, Nature Immunology.
[29] B. Nilsson,et al. Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcγRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE , 2003, Annals of the rheumatic diseases.
[30] K. Coggeshall,et al. The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors. , 2002, Blood.
[31] Y. Saeki,et al. A Point Mutation of Tyr-759 in Interleukin 6 Family Cytokine Receptor Subunit gp130 Causes Autoimmune Arthritis , 2002, The Journal of experimental medicine.
[32] P. Wiernik,et al. Systemic lupus erythematosus and B-cell hematologic neoplasm , 2001, Lupus.
[33] A. Jacob,et al. Signal Transduction by Human-Restricted FcγRIIa Involves Three Distinct Cytoplasmic Kinase Families Leading to Phagocytosis1 , 2001, The Journal of Immunology.
[34] M. Hughes,et al. Role of Src homology 2-containing-inositol 5'-phosphatase (SHIP) in mast cells and macrophages. , 2001, Biochemical Society transactions.
[35] J. Freed,et al. Differential Regulation of B Cell Development, Activation, and Death by the Src Homology 2 Domain–Containing 5′ Inositol Phosphatase (Ship) , 2000, The Journal of experimental medicine.
[36] G. Krystal,et al. A Dual Role for Src Homology 2 Domain–Containing Inositol-5-Phosphatase (Ship) in Immunity , 2000, The Journal of experimental medicine.
[37] H. Broxmeyer,et al. Altered responsiveness to chemokines due to targeted disruption of SHIP. , 1999, The Journal of clinical investigation.
[38] D. Cooney,et al. The SH2-containing 5'-inositol phosphatase (SHIP) is tyrosine phosphorylated after Fc gamma receptor clustering in monocytes. , 1999, Journal of immunology.
[39] T. Kelley,et al. FcγRIIb Modulation of Surface Immunoglobulin-induced Akt Activation in Murine B Cells* , 1999, The Journal of Biological Chemistry.
[40] J. Hamilton,et al. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. , 1998, Journal of immunology.
[41] T. Yamazaki,et al. Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. , 1998, The Journal of clinical investigation.
[42] M. Huber,et al. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Krystal,et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. , 1998, Genes & development.
[44] Y. Ohsugi,et al. IL‐6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice , 1998, Clinical and experimental immunology.
[45] E. Chan,et al. Fc gamma receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role for p42MAPK in Fc gamma receptor-stimulated TNF-alpha synthesis. , 1997, Journal of immunology.
[46] T. Tatsumi,et al. Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice. , 1997, Clinical immunology and immunopathology.
[47] P. Li,et al. ANTI‐DNA AUTOANTIBODIES STIMULATE THE RELEASE OF INTERLEUKIN‐1 AND INTERLEUKIN‐6 FROM ENDOTHELIAL CELLS , 1996, The Journal of pathology.
[48] S. Stacker,et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease , 1995, Cell.
[49] W. de Souza,et al. Subpopulations of mouse resident peritoneal macrophages fractionated on Percoll gradients show differences in cell size, lectin binding and antigen expression suggestive of different stages of maturation. , 1995, Tissue & cell.
[50] J. M. Osborne,et al. Clustering of the platelet Fc gamma receptor induces noncovalent association with the tyrosine kinase p72syk. , 1994, The Journal of biological chemistry.
[51] D. Wofsy,et al. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. , 1994, The Journal of clinical investigation.
[52] P. Hawkins,et al. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein βγ subunits , 1994, Cell.
[53] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[54] J. Ravetch,et al. FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.
[55] H. Nagafuchi,et al. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. , 1993, Journal of immunology.
[56] A. Duits,et al. Isotype‐specific cross‐linking of select human FcγR isoforms triggers release of IL‐6 , 1993 .
[57] M. Alarcón‐Riquelme,et al. Macrophage depletion decreases IgG anti‐DNA in cultures from (NZB · NZW)F1 spleen cells by eliminating the main source of IL‐6 , 1993, Clinical and experimental immunology.
[58] H. Metzger,et al. Transmembrane signaling: the joy of aggregation. , 1992, Journal of immunology.
[59] Klaus Rajewsky,et al. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.
[60] J. Miyazaki,et al. IgG1 plasmacytosis in interleukin 6 transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[61] H. Asaoku,et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas , 1988, Nature.
[62] P. Sehgal,et al. Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6). , 1988, Science.
[63] T. Kishimoto,et al. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. , 1984, Journal of immunology.
[64] H. Wagner. Endogenous TLR ligands and autoimmunity. , 2006, Advances in immunology.
[65] U. Knaus,et al. New players in TLR-mediated innate immunity , 2006 .
[66] T. Kishimoto. Interleukin-6: from basic science to medicine--40 years in immunology. , 2005, Annual review of immunology.
[67] M. Fritzler,et al. Loss of a single allele of SHIP exacerbates the immunopathology of Pten heterozygous mice , 2003, Genes and Immunity.
[68] M. Huber,et al. The role of SHIP in cytokine-induced signaling. , 2003, Reviews of physiology, biochemistry and pharmacology.
[69] G. Underhill,et al. Longevity Cells in the Maintenance of Plasma Cell The Role of Bone Marrow-Derived Stromal , 2002 .
[70] Matthew J. Silva,et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts , 2002, Nature Medicine.
[71] T. Kelley,et al. FcgammaRIIb modulation of surface immunoglobulin-induced Akt activation in murine B cells. , 1999, The Journal of biological chemistry.
[72] P. Hawkins,et al. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits. , 1994, Cell.
[73] A. Duits,et al. Isotype-specific cross-linking of select human Fc gamma R isoforms triggers release of IL-6. , 1993, Clinical and experimental immunology.